About ClinChoice
ClinChoice is a Healthcare company based in Fort Washington (United States) founded in 1995 by John D Balian and Xin Ke. CRO focused on data management, regulatory affairs and consulting services. ClinChoice has raised $212 million across 2 funding rounds from investors including Goldman Sachs, Taikang Insurance Group and Legend Capital. The company has 474 employees. ClinChoice has completed 2 acquisitions, including CROMSOURCE and CSI Medical Research. Its chief executive, as recorded, is John D Balian. Its Indian entity Clinchoice Private Limited reported revenue of ₹86.61 Cr. ClinChoice offers products and services including Clinical Development, Post-Marketing Services, and Regulatory Affairs. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Full Service. Its competitors include Emmes, Syneos Health and Veristat.
Company details
ClinChoice was established in 1995 and is based in Fort Washington, United States. As a contract research organization, focus is placed on data management, regulatory affairs, and consulting services within the pharmaceutical and biotechnology industries. Support is offered for clinical trial operations, compliance requirements, and strategic advisory needs across global markets. Co-founders include John D. Balian as CEO and Xin Ke.
- Headquarters Fort Washington, United States
- Employees 474
- Founders John D Balian, Xin Ke
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website clinchoice.com
- Social LinkedIn X YouTube
- Legal Name Clinchoice Private Limited
- Date of Incorporation 20 Apr, 2013
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹86.61 Cr
FY 2025 · -2% YoY
- Indian entity net profit₹10.30 Cr
FY 2025 · 12% margin
- Indian entity EBITDA₹14.71 Cr
FY 2025 · 17% margin
- Total Equity Funding$212M (USD)
in 2 rounds
- Latest Funding Round$150M (USD), Series E
Jul 2022
- InvestorsGoldman Sachs
& 5 more
- Employee Count474
- Investments & AcquisitionsCROMSOURCE
& 1 more
Associated legal entities of ClinChoice
ClinChoice operates through Clinchoice Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Clinchoice Private Limited CIN U85100KA2013PTC068676 | Active | 20 Apr 2013 | Bangalore, Karnataka | ₹86.6 Cr | 474 | 3 | View details |
Products & Services of ClinChoice
ClinChoice offers a comprehensive portfolio of products and services, including Clinical Development, Post-Marketing Services, and Regulatory Affairs.
Supports clinical trials and studies for drug development
Manages post-approval studies and evidence collection globally
Assists with regulatory compliance and strategic consulting
Apps and channels of ClinChoice
its YouTube channel ClinChoice Inc has 38 subscribers and 9 videos.
Videos from ClinChoice
The most watched videos on ClinChoice's YouTube channel, ClinChoice Inc (38 subscribers). Click a video to play it here.
More on ClinChoice Inc.
Funding Insights of ClinChoice
ClinChoice has successfully raised a total of $212M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $150 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $212M
- Total Rounds 2
- Last Round Series E — $150M
- First Round $62M
(Oct 2019)
- Investors Count 6
All 2 funding rounds of ClinChoice with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2022 | $150M | Series E | – | Legend Capital | |
| Oct 2019 | $62M | Series D | – | Goldman Sachs |
6 investors in total: 6 institutional.
Investors in ClinChoice
ClinChoice has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Taikang Insurance Group and Legend Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture Capital firm focused on multiple sectors | legendcapital.com.cn | Haidian, China | ||
| sherpahp.com | ||||
Apricot Capital is engaged in investing in impactful entrepreneurs. | 2018 | apricotcapital.com | Singapore, Singapore | |
Investment banking services are delivered across multiple financial sectors. | 1869 | goldmansachs.com | New York, United States | |
Life insurance company | 1996 | taikang.com | Beijing, China | |
| lillyasiaventures.com |
Investor details for ClinChoice
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Clinchoice Private Limited (ClinChoice)
Clinchoice Private Limited is the primary company behind ClinChoice. The board of Clinchoice Private Limited currently have 3 directors; the longest-serving is Mahesh Mahantappa Mudnur, appointed in 2016. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahesh Mahantappa Mudnur DIN 02820607 | Whole-time director | 11 Apr 2016 | 10 yrs 6 mo | Clinchoice Private Limited |
| Jayaraj Radhakrishna DIN 07442962 | Whole-time director | 11 Apr 2016 | 10 yrs 6 mo | Clinchoice Private Limited |
| Xin Ke DIN 08969558 | Director | 24 Nov 2020 | 5 yrs 11 mo | Clinchoice Private Limited |
People of ClinChoice
254 people are tracked at ClinChoice (79 in leadership, 175 in team); the tracked headcount is 474.
| Name | Role | Group |
|---|---|---|
John D Balian | Co-Founder & CEO | Leadership |
| Co-Founder | Leadership | |
Vijay Sivanandam | Associate Vice President - Regulatory Affairs | Leadership |
Dr. Mihir Sadadia | Associate Director, Safety Surveillance And Risk Management | Leadership |
Yuguang Zhao | Senior Vice President | Leadership |
Darby Miller | Business Development Director | Leadership |
Sheng Zhang | Executive Director, Statistical Programming | Leadership |
Temchina Na | Director, Phamacovigilance | Leadership |
Ana Q. | Director Medical Affairs | Leadership |
Hayk Davtyan | Associate Director Medical Affairs | Leadership |
Leonie B. | Director Of Business Development | Leadership |
Jianrong Li | Vice President, Biostatistics And Programming | Leadership |
| President APAC | Leadership | |
Mikki Behnke | Director Biostatistics | Leadership |
April McCall | Vice President Of Business Development | Leadership |
Syed M. Shah | Associate Director, Medical Monitoring | Leadership |
Alma Relja | Director, Regulatory Affairs | Leadership |
Tiffany Taylor | Senior Director Business Development | Leadership |
Xin Wang | Director Statistical Programmer | Leadership |
Francis de Guzman | Associate Director Human Resources | Leadership |
234 more people are available in the full profile.
Complete people profiles for ClinChoice
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of ClinChoice
Figures of Clinchoice Private Limited, the primary company behind ClinChoice, for FY 2025. Revenue was ₹86.61 Cr (-2% year on year). Net profit was ₹10.30 Cr (12% margin). EBITDA was ₹14.71 Cr (17% margin). Revenue has grown at a compounded annual rate of +11% over three years and +18% over five years.
- ₹86.61 CrRevenue · FY 2025 · -2% YoY
- ₹10.30 CrNet profit · 12% margin
- ₹14.71 CrEBITDA · 17% margin
- ₹1 LakhPaid-up capital
- 474Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +18%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Clinchoice Private Limited are on its company page.
Detailed financial statements for ClinChoice
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ClinChoice
ClinChoice has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CROMSOURCE and CSI Medical Research.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical research services for site management are provided. | csimedicalresearch.com | Singapore | 2017 | Jan 2024 | •••• | |
An ISO-certified CRO and provider of outsourced services to the pharmaceutical, biotechnology and medical device industries | cromsource.com | Verona, Italy | 1994 | Mar 2023 | •••• |
Complete acquisition details for ClinChoice
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of ClinChoice
5 dated milestones of ClinChoice across 29 years, from founding to its latest funding, stage changes and deals.
- Founded ClinChoice is founded.
- Funding First funding round of $62.0M.
- Funding Latest funding round, Series E, of $150.0M.
- Acquisition Acquires CROMSOURCE.
- Acquisition Acquires CSI Medical Research.
Competitors of ClinChoice
ClinChoice has 3 listed competitors in our database. They include Emmes, Syneos Health and Veristat.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| emmes.com | 1977 | United States | 195 | Outsourced contract research organization services are provided to clients. | ||
| syneoshealth.com | 1984 | Raleigh, United States | 29,395 | CRO clinical development services are provided by Syneos Health. | ||
| veristat.com | 1994 | Southborough, United States | 7 | Clinical trials and regulatory submissions are supported as a CRO. |
Detailed competitors of ClinChoice
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ClinChoice
The website of ClinChoice (clinchoice.com) receives about 8.8K visits a month and ranks #3,372,338 among all websites worldwide, #4,415 in Biotechnology and Pharmaceuticals.
- Monthly visits8.8K
▲ 58% vs previous month
- Unique visitors2.3K
per month
- Global rank#3,372,338
among all websites
- Category rank#4,415
Health · Biotechnology and Pharmaceuticals
- Bounce rate37%
- Pages per visit1.9
- Average visit22 sec
- DevicesDesktop 34% · Mobile 66%
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ClinChoice (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clinchoice
Complete news archive for ClinChoice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClinChoice
ClinChoice was founded in 1995 and raised its 1st funding round 24 years after it was founded.
ClinChoice is headquartered in Fort Washington, United States. It is registered at Fort Washington, Maryland, United States.
John D Balian is the CEO of ClinChoice, as recorded in our data. They have also founded this company.
ClinChoice is a funded company, having raised a total of $212M across 2 funding rounds to date. The company's 1st funding round was a Series D of $62M, raised on Oct 2019.
ClinChoice has 474 employees.
The primary company behind ClinChoice, Clinchoice Private Limited, reported revenue of ₹86.61 Cr for FY 2025, down 2% year on year.
ClinChoice was established in 1995 and is based in Fort Washington, United States. As a contract research organization, focus is placed on data management, regulatory affairs, and consulting services within the pharmaceutical and biotechnology industries. Support is offered for clinical trial operations, compliance requirements, and strategic advisory needs across global markets. Co-founders include John D. Balian as CEO and Xin Ke.
ClinChoice's top competitors include Emmes, Syneos Health and Veristat.
ClinChoice offers Clinical Development, Post-Marketing Services, and Regulatory Affairs.
ClinChoice has made 2 acquisitions, including CROMSOURCE, and CSI Medical Research.
ClinChoice has 6 investors. Key investors include Goldman Sachs, Taikang Insurance Group, Legend Capital, Sherpa Healthcare Partners, and Lilly Asia Ventures.
ClinChoice operates through Clinchoice Private Limited.